Your browser doesn't support javascript.
loading
Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel disease.
Chen, Qiu-Ling; Yin, Hao-Ran; He, Qing-Yu; Wang, Ying.
Afiliación
  • Chen QL; State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, PR China; Institute of Chinese Medical Sciences and State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, Avenida da Universidade, Taipa,
  • Yin HR; Institute of Chinese Medical Sciences and State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, Avenida da Universidade, Taipa, Macao SAR, PR China.
  • He QY; Minister of Education Key Laboratory of Tumor Molecular Biology, Jinan University, Guangzhou 510632, PR China. Electronic address: tqyhe@jnu.edu.cn.
  • Wang Y; Institute of Chinese Medical Sciences and State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, Avenida da Universidade, Taipa, Macao SAR, PR China; Minister of Education Key Laboratory of Tumor Molecular Biology, Jinan University, Guangzhou 510632, PR China. Electronic
Biomed Pharmacother ; 138: 111442, 2021 Jun.
Article en En | MEDLINE | ID: mdl-33667791

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Inflamatorias del Intestino / Sistemas de Liberación de Medicamentos / Proteína con Dominio Pirina 3 de la Familia NLR / Antiinflamatorios Tipo de estudio: Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Biomed Pharmacother Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Inflamatorias del Intestino / Sistemas de Liberación de Medicamentos / Proteína con Dominio Pirina 3 de la Familia NLR / Antiinflamatorios Tipo de estudio: Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Biomed Pharmacother Año: 2021 Tipo del documento: Article